Maternal and umbilical cord serum zidovudine levels in human immunodeficiency virus infection.

about

Maternal and fetal zidovudine pharmacokinetics during pregnancy and labour: too high dose infused at labour?Timing and mechanism of perinatal human immunodeficiency virus-1 infection.

P2860

Q34635561-E7B18772-4439-43BB-A6F1-5929E27D8DCD Q45753597-BB0407DD-B398-4974-8382-80FE90223319

P2860

Maternal and umbilical cord serum zidovudine levels in human immunodeficiency virus infection.

Item

http://www.wikidata.org/entity/Q45753600

description

1998 nî lūn-bûn

@nan

1998年の論文

@ja

1998年学术文章

@wuu

1998年学术文章

@zh

1998年学术文章

@zh-cn

1998年学术文章

@zh-hans

1998年学术文章

@zh-my

1998年学术文章

@zh-sg

1998年學術文章

@yue

1998年學術文章

@zh-hant

name

Maternal and umbilical cord se ...... unodeficiency virus infection.

@en

Maternal and umbilical cord se ...... unodeficiency virus infection.

@nl

type

Item

label

Maternal and umbilical cord se ...... unodeficiency virus infection.

@en

Maternal and umbilical cord se ...... unodeficiency virus infection.

@nl

prefLabel

Maternal and umbilical cord se ...... unodeficiency virus infection.

@en

Maternal and umbilical cord se ...... unodeficiency virus infection.

@nl

P1476

Maternal and umbilical cord se ...... unodeficiency virus infection.

@en

P2093

Chaovavanich A

http://www.w3.org/2001/XMLSchema#string

Phuapradit W

http://www.w3.org/2001/XMLSchema#string

Puchaiwatanon O

http://www.w3.org/2001/XMLSchema#string

Sirinavin S

http://www.w3.org/2001/XMLSchema#string

Sunthornkachit R

http://www.w3.org/2001/XMLSchema#string

Taneepanichskul S

http://www.w3.org/2001/XMLSchema#string

Wiratchai A

http://www.w3.org/2001/XMLSchema#string

P2860

Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.

Phase I evaluation of zidovudine administered to infants exposed at birth to the human immunodeficiency virus.

Factors predictive of maternal-fetal transmission of HIV-1. Preliminary analysis of zidovudine given during pregnancy and/or delivery.

Least microtransfusion from mother to fetus in elective cesarean delivery.

Erratic zidovudine bioavailability in HIV seropositive patients.

P304

288-292

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1479-828X.1998.TB03068.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

1998-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

9761155

http://www.w3.org/2001/XMLSchema#string

Maternal and umbilical cord serum zidovudine levels in human immunodeficiency virus infection.

about

P2860

P2860

Maternal and umbilical cord serum zidovudine levels in human immunodeficiency virus infection.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698